全球刺血针和采血设备市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球刺血针和采血设备市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Lancet And Lancing Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 4.00 Billion
Diagram Market Size (Forecast Year)
USD 6.38 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Abbott
  • B.Braun
  • ARKRAY
  • Terumo
  • I

全球刺血针和采血设备市场,按药物类别(卡比多巴、左旋多巴、多巴胺受体激动剂、MAO 抑制剂)、最终用户(医院、专科诊所、其他)、设备类型(可重复使用、一次性、安全刺血针、家庭护理刺血针)、按应用(胆固醇测试、血红蛋白测试、凝血测试、葡萄糖测试、其他)、产品类型(专业刺血针、个人刺血针)分销渠道(医院药房、诊所、零售药房、其他)划分 - 行业趋势和预测到 2030 年。 

刺血针和采血设备市场

刺血针和采血设备市场分析和规模

日常糖尿病治疗的一个重要部分是戳手指并取一滴血来评估血糖水平。即使是那些使用连续血糖监测仪 (CGM) 的人,偶尔也需要检​​查和校准一滴新血。然而,这种血液检测方法往往令人不舒服且疼痛。采血工具和刺血针通常不被检查。人们通常使用血糖仪附带的用品。刺血针及其针头在向指尖移动时清晰可见,并且是相当大的弹簧加载装置的一部分。幸运的是,现代采血装置隐藏了刺血针针头,这使得该过程不那么可怕,意外射血的可能性也更低。

Data Bridge Market Research 分析,刺血针和采血设备市场在 2022 年的规模为 40 亿美元,预计到 2030 年将达到 63.8 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

刺血针和采血设备市场范围和细分  

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

药物类别(卡比多巴、左旋多巴、多巴胺受体激动剂、MAO 抑制剂)、最终用户(医院、专科诊所、其他)、设备类型(可重复使用、一次性、安全采血针、家庭护理采血针)、按用途(胆固醇测试、血红蛋白测试、凝血测试、葡萄糖测试、其他)、产品类型(专业采血针、个人采血针)分销渠道(医院药房、诊所、零售药房、其他)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott (U.S.), B. Braun SE (Germany), ARKRAY, Inc. (Japan), Terumo Corporation (Japan), I-SENS, Inc. (South Korea), Nipro Medical Corporation (Japan), Omron Corporation (Japan), AgaMatrix (U.S.), Smiths Group plc (U.S.), SARSTEDT AG& CO. K.G. (Germany), Yu Yue medical (China), Greiner Bio One International GmbH (Austria), EDAN Instruments, Inc. (China), Jiangsu huida medical instruments co. Ltd (China), B.D. (U.S.), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), Owen Mumford Ltd (U.K.), Medtronic (Ireland), Ypsomed AG (Switzerland)

Market Opportunities

  • Growing geriatric population
  • Increasing chronic diseases

Market Definition

Lancing is regarded as an important component of diabetic treatment. Lancets are small, sharp-edged devices that are used to puncture the skin. The user can test the blood glucose level by taking a tiny amount of blood from the skin and using a blood glucose monitor and test strips. Lancing devices are designed to keep a lancet in position. These devices can be operated by pressing a button. Different lancing device settings may be required depending on the patient's skin type. Lancets are designed to be used only once. They should be properly disposed of once they have been used.

Global Lancet and Lancing Devices Market Dynamics

Drivers

  • Favorable reimbursement options

Diabetes and anemia are expected to drive demand for lancets and lancing devices during the forecast period. According to the International Diabetes Federation, approximately 245 million adults aged 20 to 79 had diabetes in 2017, which is expected to rise to 629 million by 2045. According to estimates, 79% of diabetic adults live in low- and middle-income countries. Diabetes claimed the lives of approximately 4 million people in 2017, and healthcare spending on the disease totaled at least $727 billion in 2017, accounting for about 12% of total adult healthcare spending.

  • Growing geriatric population

The global geriatric population (those aged 65 and up) is expected to reach 1 billion by 2050, creating a large pool of patients vulnerable to chronic diseases such as type 2 diabetes. This will increase demand for lancet needles and other related products used in diagnostics and treatment worldwide.

Opportunities

  • Increasing incidence of diabetes and other chronic diseases

Diabetes' global prevalence is expected to rise from 9% in 2013 to 11% by 2030. This will result in many patients requiring regular blood glucose monitoring and treatment, driving demand for lancing devices.

The development of new lancing devices with features like adjustable depth, vibration feedback, and pre-set depths is expected to drive the lancet and lancing devices market forward.

Restraints/Challenges

  • High costs associated with the device

High costs associated with device usage and a lack of awareness among people about the benefits of these devices in developing economies will likely propel the growth of the lancet and lancing devices market during the forecast period. The FreeStyle Lancing Devices must be used with the FreeStyle Lancets. They cost about $15 per box (without insurance), and each box contains 100 lancets. Four depth settings for personalised finger sticks

This lancet and lancing devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lancet and lancing devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lancet and Lancing Devices Market Scope

The lancet and lancing devices market is segmented on the basis of product type, drug class, application, distribution channel, device type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

  • Carbidopa
  • Lebodopa
  • Dopamine Receptor Agonist
  • MAO-inhibitors

 End-Users

  • Hospitals
  • Specialty Clinics
  • Others

 Device Type

  • Reusable
  • Disposable
  • Safety Lancets
  • Homecare Lancets

Application

  • Cholesterol Tests
  • Hemoglobin Testing
  • Coagulation Testing
  • Glucose Tests
  • Other

Distribution Channel

  • Hospital Pharmacy
  • Clinics
  • Retail Pharmacy
  • Others

Product Type

  • Professional Lancets
  • Pressure-activated Lancets
  • Push-button Lancets
  • Side-button Lancets
  • Personal Lancets

Lancet and Lancing Devices Market Regional Analysis/Insights

The lancet and lancing devices market is analysed and market size insights and trends are provided by country, product type, drug class, application, distribution channel, device type and end user as referenced above.

刺血针和采血设备市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于优惠的报销政策盛行以及贫血症和糖尿病发病率的不断上升,北美在刺血针和刺血设备市场占据主导地位,而印度则在刺血针和刺血设备市场占据主导地位。

由于医疗保健服务投资水平不断飙升且研发活动成本低廉,预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

采血针和采血设备市场还为您提供每个国家/地区资本设备医疗保健支出增长、采血针和采血设备市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对采血针和采血设备市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和刺血针和采血设备市场份额分析

刺血针和采血设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对刺血针和采血设备市场的关注有关。

刺血针和采血设备市场的一些主要参与者包括:

  • 雅培(美国)
  • B.Braun SE(德国)
  • ARKRAY 株式会社(日本)
  • 泰尔茂株式会社 (日本)
  • I-SENS, Inc.(韩国)
  • Nipro Medical Corporation(日本)
  • 欧姆龙株式会社(日本)
  • AgaMatrix (美国)
  • 史密斯集团有限公司 (美国)
  • SARSTEDT AG& CO. KG(德国)
  • 鱼跃医疗(中国)
  • Greiner Bio One International GmbH(奥地利)
  • EDAN Instruments, Inc.(中国)
  • 江苏惠达医疗器械有限公司 (中国)
  • BD(美国)
  • 赛诺菲(法国)
  •  F. Hoffmann-La Roche Ltd(瑞士)
  •  拜耳公司(德国)
  •  Owen Mumford Ltd(英国)
  •  美敦力(爱尔兰)
  •  Ypsomed AG(瑞士)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Lancet and Lancing Devices Market, By Drug Class (Carbidopa, Lebodopa, Dopamine Receptor Agonist, MAO-inhibitors), End-Users (Hospitals, Specialty Clinics, Others), Device Type (Reusable, Disposable, Safety Lancets, Homecare Lancets), By Application (Cholesterol Tests, Hemoglobin Testing, Coagulation Testing, Glucose Tests, Other), Product Type (Professional Lancets, Personal Lancets) Distribution Channel (Hospital Pharmacy, Clinics, Retail Pharmacy, Others) – Industry Trends and Forecast to 2030.  .
The Global Lancet And Lancing Devices Market size was valued at USD 4.00 USD Billion in 2022.
The Global Lancet And Lancing Devices Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, B.Braun, ARKRAY, Terumo, I,SENS, Nipro Medical, Omron, AgaMatrix, Smiths Group, SARSTEDT, Yu Yue Medical, Greiner Bio One International, EDAN Instruments, Jiangsu huida medical instruments, B.D., Sanofi, F. Hoffmann-La Roche, Bayer, Owen Mumford, Medtronic, Ypsomed AG..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..